medicines in the European Union. The purpose of the study was to learn whether
participants were still alive after completing the TOWER study.
4. Who Was Included in This Study?
Who took part in the study?
This study included 75 participants who had participated in the TOWER study.
42 participants (56%, or about 56 out of 100) were men and 33 participants (44%, or
about 44 out of 100) were women. At the start of the TOWER study, these
participants ranged in age from 19 to 80 years. 37 participants (49%, or about 49
out of 100) were younger than 35 years old, 20 participants (27%, or about 27 out of
100) were 35 to 54 years old, 10 participants (13%, or about 13 out of 100) were 55
to 64 years old, and 8 participants (11%, or about 11 out of 100) were at least 65
years old.
3